<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Machado LA</submitter><funding>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</funding><pagination>170</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7468422</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7</volume><pubmed_abstract>HIV-1 integrase is the enzyme responsible for integrating the viral DNA into the host genome and is one of the main targets for antiretroviral therapy; however, there are documented cases of resistance against all the currently used integrase strand transfer inhibitors (INSTIs). While some resistance-related mutations occur near the inhibitor's binding site, the mutation N155H occurs on the opposite side of the drug-interacting Mg&lt;sup>2+&lt;/sup> ions, thus, not interacting directly with the drug molecules and currently lacking an explanation for its resistance mechanism. Moreover, mutation N155H and the resistance-related mutation Q148H are mutually exclusive for unknown reasons. In the present study, we use molecular dynamics simulations to understand the impact of the N155H mutation in the</pubmed_abstract><journal>Frontiers in molecular biosciences</journal><pubmed_title>Evidence for Disruption of Mg&lt;sup>2+&lt;/sup> Pair as a Resistance Mechanism Against HIV-1 Integrase Strand Transfer Inhibitors.</pubmed_title><pmcid>PMC7468422</pmcid><funding_grant_id>(CAPES) - Finance Code 001</funding_grant_id><pubmed_authors>Machado LA</pubmed_authors><pubmed_authors>Guimaraes ACR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evidence for Disruption of Mg&lt;sup>2+&lt;/sup> Pair as a Resistance Mechanism Against HIV-1 Integrase Strand Transfer Inhibitors.</name><description>HIV-1 integrase is the enzyme responsible for integrating the viral DNA into the host genome and is one of the main targets for antiretroviral therapy; however, there are documented cases of resistance against all the currently used integrase strand transfer inhibitors (INSTIs). While some resistance-related mutations occur near the inhibitor's binding site, the mutation N155H occurs on the opposite side of the drug-interacting Mg&lt;sup>2+&lt;/sup> ions, thus, not interacting directly with the drug molecules and currently lacking an explanation for its resistance mechanism. Moreover, mutation N155H and the resistance-related mutation Q148H are mutually exclusive for unknown reasons. In the present study, we use molecular dynamics simulations to understand the impact of the N155H mutation in the</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2026-04-14T03:10:10.566Z</modification><creation>2025-05-31T23:51:51.128Z</creation></dates><accession>S-EPMC7468422</accession><cross_references><pubmed>32974383</pubmed><doi>10.3389/fmolb.2020.00170</doi></cross_references></HashMap>